» Articles » PMID: 33981470

International Society of Nephrology Global Kidney Health Atlas: Structures, Organization, and Services for the Management of Kidney Failure in the Middle East

Abstract

Kidney failure is the permanent impairment of kidney function associated with increased morbidity, hospitalization, and requirement for kidney replacement therapy. A total of 11 countries in the Middle East region (84.6%) responded to the survey. The prevalence of chronic kidney disease in the region ranged from 5.2% to 10.6%, whereas prevalence of treated kidney failure ranged from 152 to 826 per million population. Overall, the incidence of kidney transplantation was highest in Iran (30.9 per million population) and lowest in Oman and the United Arab Emirates (2.2 and 3.0 per million population, respectively). Long-term hemodialysis services were available in all countries, long-term peritoneal dialysis services were available in 9 (69.2%) countries, and transplantation services were available in most countries of the region. Public funding covered the costs of nondialysis chronic kidney disease care in two-thirds of countries, and kidney replacement therapy in nearly all countries. More than half of the countries had dialysis registries; however, national noncommunicable disease strategies were lacking in most countries. The Middle East is a region with high burden of kidney disease and needs cost-effective measures through effective health care funding to be available to improve kidney care in the region. Furthermore, well-designed and sustainable health information systems are needed in the region to address current gaps in kidney care in the region.

Citing Articles

Decarbonisation of Kidney Care in the United Arab Emirates: A Roadmap to an Environmentally Sustainable Care.

Holt S, Koornneef E, Al Obeidli A, Hubbert L, Nicholson L Int J Nephrol Renovasc Dis. 2024; 17:241-253.

PMID: 39430398 PMC: 11490247. DOI: 10.2147/IJNRD.S481121.


Prevalence and assessment of risk factors of chronic kidney disease in the ASIR region of Saudi Arabia.

Alshahrani M, Almalki L, Hasoosah N, Alahmari A, Alqahtani A, Alqahtani A Ann Med Surg (Lond). 2024; 86(7):3909-3916.

PMID: 38989199 PMC: 11230802. DOI: 10.1097/MS9.0000000000001755.


Capacity for the management of kidney failure in the International Society of Nephrology Middle East region: report from the 2023 ISN Global Kidney Health Atlas (ISN-GKHA).

Karam S, Amouzegar A, Alshamsi I, Al Ghamdi S, Anwar S, Ghnaimat M Kidney Int Suppl (2011). 2024; 13(1):57-70.

PMID: 38618498 PMC: 11010631. DOI: 10.1016/j.kisu.2024.01.009.


Mortality and disability-adjusted life years in North Africa and Middle East attributed to kidney dysfunction: a systematic analysis for the Global Burden of Disease Study 2019.

Rashidi M, Moghaddam S, Azadnajafabad S, Mohammadi E, Khalaji A, Malekpour M Clin Kidney J. 2024; 17(1):sfad279.

PMID: 38288035 PMC: 10823484. DOI: 10.1093/ckj/sfad279.


Machine Learning Approaches: Detecting the Disease Variants in Human-Exhaled Breath Biomarkers.

Selvaraj B, Rajasekar E, Rayappan J ACS Omega. 2024; 9(1):215-226.

PMID: 38222575 PMC: 10785631. DOI: 10.1021/acsomega.3c03755.


References
1.
Heidary Rouchi A, Mahdavi-Mazdeh M . Kidney transplantation in the Middle East. Clin Nephrol. 2016; 86 (2016)(13):101-105. DOI: 10.5414/CNP86S109. View

2.
El-Reshaid W, El-Reshaid K, Kapoor M, Hakim A . Chronic renal disease in Kuwaiti nationals: a prospective study during the past 4 years. Ren Fail. 2005; 27(2):227-33. View

3.
Hassanien A, Al-Shaikh F, Vamos E, Yadegarfar G, Majeed A . Epidemiology of end-stage renal disease in the countries of the Gulf Cooperation Council: a systematic review. JRSM Short Rep. 2012; 3(6):38. PMC: 3386663. DOI: 10.1258/shorts.2012.011150. View

4.
Suleymanlar G, Serdengecti K, Altiparmak M, Jager K, Seyahi N, Erek E . Trends in renal replacement therapy in Turkey, 1996-2008. Am J Kidney Dis. 2011; 57(3):456-65. DOI: 10.1053/j.ajkd.2010.12.007. View

5.
Cho N, Shaw J, Karuranga S, Huang Y, da Rocha Fernandes J, Ohlrogge A . IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018; 138:271-281. DOI: 10.1016/j.diabres.2018.02.023. View